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The treatment of soft tissue defects still poses a clinical problem in
reconstructive medicine e.g. after surgical trauma. Adipose-
derived stem cells have already been used for several tissue
engineering approaches including adipose tissue engineering. Fi-
brin has already been reported to be a suitable matrix to support
several cell types. This study evaluates the inﬂuence of ﬁbrin
composition on the formation of an adipose tissue-equivalent
in vitro using adipose-derived stem cells (ASC). Undifferentiated
ASC were mixed with thrombin and added to the ﬁbrinogen com-
ponent. Subsequently, ﬁbrin constructs were either cultivated in
control or adipogenic induction medium and weekly analyzed. The
inﬂuence of ﬁbrinogen concentration on ﬁbrin structure was eval-
uated by scanning electronmicroscopy, its inﬂuence on cell viability
was demonstrated by CalceinAM/DAPI staining and quantiﬁed
by lactate-dehydrogenase (LDH) measurement. Adipogenic con-
version was demonstrated by Oil Red O staining after cryo-
sectioning, by leptin ELISA and by quantitative RT-PCR for the
adipogenic markers PPAR-a, FABP-4 and leptin. Fibrin propagates
ASC growth and adipogenic differentiation. The highest cell density
was observed when 50 mg/mL ﬁbrinogen were used whereas adi-
pogenic conversion was more pronounced when lower ﬁbrinogen
concentrations were applied. Interestingly, adding ASC to the ﬁbrin
matrix led to a stabilization of the construct by inﬂuencing the
structure. Combining ﬁbrin and ASC is a suitable approach for soft
tissue regeneration. The ﬁbrinogen concentration has an inﬂuence
on matrix structure, cell morphology and density. However, adi-
pogenic differentiation is also affected by donor variability.
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Tissue engineering strategies frequently include a scaffold, living
cells and bioactive substances to promote cell growth and guide
cell differentiation. The encapsulation in carriers enables protects
the bioactivity of those substances upon implantation, avoids being
transported by the body ﬂuids and also allows controlling the re-
lease rate. Encapsulation materials are preferably biodegradable
polymers. In this work, all-trans retinoic acid (atRA) was used as a
model bioactive agent; since it was shown that atRA enhances the
expression of osteocalcin, a speciﬁc osteogenic marker.
atRA was encapsulated into polyester microcapsules by a water/
oil/water double emulsion/solvent evaporation technique. The
polyesters used in this study are poly(butylene succinate) (PBS),
poly(butylene succinate-co-adipate) (PBSA) and poly(butylene
terephthalate-co-adipate) (PBTA). The kinetics of atRA release
was studied in phosphate buffered saline solution of pH 7.4 at 378C
under orbital shaking.
Encapsulation efﬁciencies (EE) of 94.0%, 95.4% and 95.8%
were obtained for PBS, PBSA and PBTA, respectively. The high
EE is probably due to the low water solubility of atRA which is
entrapped in the organic phase and does not dissolve into the
aqueous phase.
atRA was released from PBS and PBSA steadily with an aver-
age release of 12.6% and 9.9%, respectively, after 4weeks. Release
from PBTA showed a burst of 12.8% within the ﬁrst 24 hours, fol-
lowed by a slower release stage, reaching 34.0% after 4weeks.
The results obtained in this study demonstrate the interest of this
strategy and show the potential of the proposed microcapsules as
carriers for the controlled release of bioactive agents.
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Changes in muscular ubiquitin gene and protein expression in ac-
cordance with nerve injury and regeneration process were evaluated.
Sciatic nerve of 12week old SD rat was induced nerve paralysis.
Gastrocnemius muscle of both intact and injured lower extremity
were harvested at 5, 10, 20 and 40 days post injury. Contractility
and wet weight of the gastrocnemius muscle was measured and
compared with the normal muscle. RT-PCR was done for ubiquitin
gene detection, and ubiqutin protein expression in the harvested
tissue was also checked by immunohistochemisty for the evalua-
tion of expression pattern as the time sequence.
The muscle weight decreased starting the 10th day and was at the
lowest at 20th day. A recovery in weight was evident starting 40th
day. Pre-harvest degree of muscle contraction showed no changes in
the ﬁrst 5 days. At 10th day, partial recovery was noted and at 20th
day, same degree of contraction was noted compared to the normal
muscle. Degree of ubiquitin expression from the extracted mRNA
showed most activity at the 10th day. At 40th day, the degree of
expression was about the same as the normal muscle. The degree in-
creased starting the 10th day and at 20th day, much ubiquitin stained
myoﬁbers emerged and the recovery was noted at the 40th day.
Ubiquitin proteolysis seems to be involved in muscle wasting in
the reversible nerve injury. It was observed that this particular gene
and protein increased in expression during a muscle wasting process.
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Introduction: Primary alveolar cleft repair treating congenital al-
veolar clefts with gingivoperiosteoplasty (GPP) has a 60% success
rate. The remaining 40% have persistent alveolar defects requiring
secondary grafting, potentially complicated by donor-site morbid-
ity, graft resorption, and infection. Herein, we describe a novel
critical-size defect GPP model using tissue-engineered scaffolds to
improve bone healing and circumvent secondary grafting.
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